I agree that this site is using cookies. You can find further informations here.
X
Cattran, Daniel C
183  results:
Search for persons X
?
1

Rituximab or cyclosporine A for the treatment of membranous..:

Kadatz, Matthew ; Klarenbach, Scott ; So, Helen...
Nephrology Dialysis Transplantation.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Focal Segmental Glomerulosclerosis: Assessing the Risk of R..:

Troyanov, Stéphan ; Jauhal, Arenn ; Reich, Heather N....
Kidney International Reports.  8 (2023)  11 - p. 2403-2415 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Mayo Clinic Consensus Report on Membranous Nephropathy: Pro..:

Sethi, Sanjeev ; Beck Jr., Laurence H. ; Glassock, Richard J....
Mayo Clinic Proceedings.  98 (2023)  11 - p. 1671-1684 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Genome-wide association analyses define pathogenic signalin..:

Kiryluk, Krzysztof ; Sanchez-Rodriguez, Elena ; Zhou, Xu-Jie...
Nature Genetics.  , 2023
Link: https://doi.org/10.1038/..
 
?
5

Mayo Clinic consensus report on membranous nephropathy: pro..:

Sethi, Sanjeev ; Beck Jr., Laurence H. ; Glassock, Richard J....
Kidney International.  104 (2023)  6 - p. 1092-1102 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Precision nephrology identified tumor necrosis factor activ..:

Mariani, Laura H. ; Eddy, Sean ; AlAkwaa, Fadhl M....
Kidney International.  103 (2023)  3 - p. 565-579 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Evaluating Progression Risk in Patients With Immunoglobulin..:

Cattran, Daniel C. ; Floege, Jürgen ; Coppo, Rosanna
Kidney International Reports.  8 (2023)  12 - p. 2515-2528 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Quantifying the benefits of remission duration in focal and..:

Jauhal, Arenn ; Reich, Heather N ; Hladunewich, Michelle...
Nephrology Dialysis Transplantation.  38 (2022)  4 - p. 950-960 , 2022
Link: https://doi.org/10.1093/..
 
?
9

Improving Clinical Trials for Anticomplement Therapies in C..:

Bomback, Andrew S. ; Appel, Gerald B. ; Gipson, Debbie S....
American Journal of Kidney Diseases.  79 (2022)  4 - p. 570-581 , 2022
Link: https://doi.org/10.1053/..
 
?
10

The Canadian Glomerulonephritis Registry (CGNR) and Transla..:

Hildebrand, Ainslie M. ; Barua, Moumita ; Barbour, Sean J....
Canadian Journal of Kidney Health and Disease.  9 (2022)  - p. 205435812210890 , 2022
Link: https://doi.org/10.1177/..
 
?
11

Immunoglobulin A nephropathy is characterized by anticommen..:

Currie, Elissa G. ; Coburn, Bryan ; Porfilio, Elisa A....
JCI Insight.  7 (2022)  5 - p. , 2022
Link: https://doi.org/10.1172/..
 
?
12

Application of the International IgA Nephropathy Prediction..:

Barbour, Sean J. ; Coppo, Rosanna ; Zhang, Hong...
Kidney International.  102 (2022)  1 - p. 160-172 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Slowly Unraveling the Mysteries of C3G:

Cattran, Daniel C. ; Sethi, Sanjeev
American Journal of Kidney Diseases.  77 (2021)  5 - p. 670-672 , 2021
Link: https://doi.org/10.1053/..
 
?
14

Evaluation of the Pharmacokinetics and Exposure–Response Re..:

van der Aart-van der Beek, Annemarie B. ; Koomen, Jeroen V. ; Dekkers, Claire C. J....
Clinical Pharmacokinetics.  60 (2021)  4 - p. 517-525 , 2021
Link: https://doi.org/10.1007/..
 
?
15

How to optimize the design and implementation of risk predi..:

Gagliardi, Anna R. ; Reich, Heather N. ; Cattran, Daniel C..
BMC Medical Informatics and Decision Making.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
1-15